Literature DB >> 26581315

Recent Patents of Complementary and Alternative Medicine for Allergic Rhinitis.

Kam L Hon1, Ching K Fung, Alexander K C Leung, Hung S Lam, So L Lee.   

Abstract

Allergic rhinitis (AR) is a common respiratory disease affecting both adults and children worldwide. Affected patients may experience nasal congestion/stuffiness, rhinorrhea (anterior and/or posterior), nasal/ nasopharyngeal itching and sneezing. Allergen avoidance is the principal step in the management. Nasal saline irrigation to remove allergen (s) in the nose is a useful adjunctive therapy in the management of moderate to severe AR. Symptomatic relief and improved quality of life may be achieved in the majority of patients with appropriate pharmacotherapy. Mild-to-moderate cases are usually managed with either an oral second generation antihistamine or an intranasal corticosteroid. More severe cases may require treatment with an intranasal corticosteroid in combination with various oral medications. Patients who require medications for more than 6 months per year or have intolerable side effects from pharmacotherapy can be considered for immunotherapy. A wide range of complementary and alternative medicines (CAM) have also been proposed. This overview evaluates the evidence of use of CAM for AR. Some methods including acupuncture and herbal medicine have supportive evidence, but the efficacy of other CAM is controversial. Conversely, possible side effects of different modalities are often inadequately documented. The herbal formulae include Butterbur, Nigella sativa, Shi-Bi-Lin, Polyherbal formula, Grapeseed extract, Rosmarinic acid, Spirulina, Biminne, and Bhu-zhong-yi-qi-tong. Further research is needed to assess the efficacy and safety before they are employed in treating AR. This review article also discusses recent CAM patents for use in AR, which are exclusively traditional Chinese medicine (TCM) concoctions primarily for oral consumption but two as topical spray. Only 8 pertinent patents, all TCM compositions for treating AR and registered in 2014, were obtained. Description about their efficacy is impressive but objective outcome evaluation tools are lacking.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26581315     DOI: 10.2174/1872213x10666151119144718

Source DB:  PubMed          Journal:  Recent Pat Inflamm Allergy Drug Discov        ISSN: 1872-213X


  4 in total

1.  Qingfeijianpi therapy for persistent allergic rhinitis: A randomized, positive-controlled clinical trial.

Authors:  Jing Qu; Chang Liu; Hai-Hong Lian; Xiang-Dong Wang; Nan Zhi
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

2.  Acupuncture and herbal moxibustion for the treatment of 'BiQiu' (allergic rhinitis symptoms) in a Hong Kong Chinese medicine clinic: a randomized controlled trial.

Authors:  Ting Yiu Yung; Hongwei Zhang; Lap Che Tang; Lang Zhang; Chak On Law; Wai Man Tam; Chun Wai Chan; Heng Chun Chen; Man Hork Lee; Tat Chi Ziea; Fung Leung Ng; Zhi Xiu Lin
Journal:  Chin Med       Date:  2019-11-08       Impact factor: 5.455

Review 3.  Acute bacterial sinusitis in children: an updated review.

Authors:  Alexander Kc Leung; Kam Lun Hon; Winnie Cw Chu
Journal:  Drugs Context       Date:  2020-11-23

4.  Clinical acupuncture therapy for children with allergic rhinitis: A protocol for systematic review and meta analysis.

Authors:  Jun Li; Lanhua Liu; Lin Jiao; Kai Liao; LingnLing Xu; Xiaohong Zhou; Jun Xiong
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.